In 2024, Sanxing Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Sanxing Medical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 |
|---|---|---|
Total Scope 1 | 1,500.98a | 1,216.4b |
Total Scope 2 | ||
Market-Based | 32,040.2a | N/A |
Location-Based | N/A | N/A |
Unspecified Calculation Method | N/A | 41,486.59b |
Total Scope 3 | N/A | N/A |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0.7503a | 0.7542b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Sanxing Medical amounted to 33,541.18 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sanxing Medical decreased by 21.45%, showing that the company has made progress in taking action to reduce the climate impact of its operations.ab
In 2024, the total Scope 1 emissions of Sanxing Medical were 1,500.98 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2023), Sanxing Medical's Scope 1 emissions increased by 23.4%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.ab
In 2024, Sanxing Medical reported Scope 2 greenhouse gas (GHG) emissions of 32,040.2 tCO₂e using the market-based method.a
In 2024, Sanxing Medical reported its Scope 2 emissions using the market-based method.a
In 2024, Sanxing Medical reported Scope 1 greenhouse gas (GHG) emissions of 1,500.98 tCO₂e and total revenues of USD 2,001 millions. This translates into an emissions intensity of 0.75 tCO₂e per millions USD.a
In 2024, Sanxing Medical reported a Scope 1 emissions intensity of 0.75 tCO₂e per millions USD. Compared to the peer group median of 1.8, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2024, Sanxing Medical ranked 6 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Sanxing Medical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a